Skip to main content

Table 2 Change in highly active antiretroviral therapy (HAART) following MCNS diagnosis

From: Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases

Patient

HAART before MCNS diagnosis

Change in HAART at the time of MCNS occurrence

1

EVILTEGRAVIR

COBICISTAT

TENOFOVIR

EMTRICITABINE

No change

2

EMTRICITABINE

TENOFOVIR

ETRAVIRINE

ABACAVIR

LAMIVUDINE

ETRAVIRINE

3

RALTEGRAVIR

TENOFOVIR

NEVIRAPINE

RALTEGRAVIR

NEVIRAPINE

4

EMTRICITABINE

TENOFOIR

RILPIVIRINE

No change

5

LAMIVUDINE

ZIDOVUDINE

LOPINAVIR

No change

6

RALTEGRAVIR

ETRAVIRINE

No change

7

ABACAVIR

LOPINAVIR

ETRAVIRINE

ABACAVIR

LAMIVUDINE

DIDANOSINE

LOPINAVIR

8

None

None (HAART introduction 4 years after diagnosis)